NCBI PubMed Central
open access
Long-term impact of disclosing amyloid PET results to individuals with subjective cognitive decline.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Patient-reported outcomes - the missing link to advancing light chain (AL) amyloidosis clinical research.#209461
- On the crossroads of interdisciplinary medicine in amyloidosis - study protocol for a single-center interdisciplinary registry study.#255305
- Effect of apolipoprotein ε4 allele on hippocampal and brain volume in intractable temporal lobe epilepsy.#224777
- Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 Trial.#354641
- Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change.#161815
Record · ID 161751
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive